FDA-cleared for the treatment of depression, EXOMIND’s patented ExoTMS™ technology offers a non-invasive therapy that comfortably stimulates key areas of the brain involved in emotional regulation, cognitive function, and self-control. TMS treatment harnesses the brain’s natural neuroplasticity to support lasting wellness and mental health solutions, providing a safe and effective option for those seeking innovative approaches to psychiatric conditions and overall well-being.

TMS treatment offers mental health solutions that support improved mood regulation and mental clarity, enabling top performers to maintain focus even under high-pressure demands with this non-invasive therapy.

With no systemic side effects and minimal downtime, TMS treatment serves as an effective non-invasive therapy that fits seamlessly into the schedules of executives, physicians, entrepreneurs, and other driven professionals seeking mental health solutions.

Many high-functioning individuals find that mental health solutions like structured, evidence-based TMS treatment lead to better concentration, enhanced decision-making capacity, and restored motivation through this non-invasive therapy.

TMS treatment is FDA-cleared for addressing treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and nicotine dependence. This non-invasive therapy is primarily recommended for adults who have not experienced success with at least one or two adequate antidepressant trials. Additionally, there is emerging evidence supporting its effectiveness as a mental health solution for bipolar depression, post-traumatic stress disorder (PTSD), and substance use disorders.
While traditional TMS treatment for depression typically requires 20 to 36 sessions (five days a week for 4-6 weeks), Exomind offers mental health solutions through a non-invasive therapy approach that often involves about 6 sessions. However, some treatment plans may extend to 20 or 30 sessions, depending on the patient's specific condition and goals.
TMS treatment is generally well tolerated as a non-invasive therapy for mental health solutions. The most common side effects include headache and scalp discomfort, along with fatigue, pain, dizziness, insomnia, and mild eye or nasal symptoms. Serious adverse events, such as seizures, are rare and typically occur in patients with predisposing factors. While there is no evidence that TMS induces hypomania in unipolar depression, affective switches may occur in individuals with bipolar disorder.
Predictors of a favorable response to mental health solutions include younger age, lower degrees of treatment resistance, absence of comorbid anxiety or psychotic symptoms, and being female. Utilizing TMS treatment as a maintenance therapy and combining it with other non-invasive therapy options may enhance the durability of the response. Moreover, an incomplete initial response and the presence of comorbid anxiety are linked to higher relapse rates after TMS.
Check out this great video on how TMS treatment, a non-invasive therapy, works on the neurons in the brain, offering valuable mental health solutions.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.